Announcements Trials
Browse Landscape

Phase

Phase 2 73Phase 1 40Phase 3 28Phase 1/2 24Phase NA 9Phase 4 6Phase EARLY_PHASE1 2Phase 2/3 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Colorectal Neoplasms 7Glioblastoma 6Breast Neoplasms 6Neoplasms 5Lymphoma, B-Cell 5Glioma 5Neoplasm Metastasis 4Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Melanoma 3Head and Neck Neoplasms 3Stomach Neoplasms 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Pancreatic Ductal Adenocarcinoma 2Multiple Myeloma 2Lymphoma 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Solid Tumors 1Solid Tumor 1Smoking Cessation 1Smoking 1Sarcoma, Synovial 1Rectal Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Multiple Myeloma × 30 days × Clear all
NCT07577206 2026-05-11

Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.

National Cancer Institute, Naples

Phase EARLY_PHASE1 Recruiting
10 enrolled
Plasma cell

Multiple Myeloma

NCT06663046 2026-05-07

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma

Wondercel Biotech (ShenZhen)

Phase EARLY_PHASE1 Suspended
30 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡